Progeny 3 Inc’s Danimer Scientific, Inc. DNMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-16,847
Closed -$1.39M 25
2023
Q3
$1.39M Hold
16,847
0.19% 21
2023
Q2
$1.6M Hold
16,847
0.24% 22
2023
Q1
$2.32M Hold
16,847
0.39% 22
2022
Q4
$1.21M Buy
16,847
+3,803
+29% +$360K 0.21% 22
2022
Q3
$1.54M Hold
13,044
0.26% 22
2022
Q2
$2.38M Hold
13,044
0.48% 18
2022
Q1
$3.06M Buy
13,044
+5,280
+68% +$1.07M 0.57% 19
2021
Q4
$2.65M Buy
7,764
+4,198
+118% +$2.31M 0.72% 19
2021
Q3
$2.33M Buy
3,566
+3,360
+1,631% +$2.47M 0.58% 24
2021
Q2
$206K Buy
+206
New +$205K 0.07% 26

Other funds holding DNMR

Progeny 3 Inc's DNMR Position: Q4 2023 in Review

Progeny 3 Inc sold out of Danimer Scientific, Inc. (DNMR) in Q4 2023, closing a stake of 16,847 shares — an estimated $1.39M sold.

Progeny 3 Inc first reported a position in DNMR in Q2 2021 and held it in 10 quarters. The position peaked at $3.06M in Q1 2022. 140 funds tracked by Wall St. Rank hold DNMR as of Q4 2023.

  • Progeny 3 Inc reported no remaining Danimer Scientific, Inc. position as of Q4 2023 after selling out during the quarter.
  • Progeny 3 Inc sold 16,847 Danimer Scientific, Inc. shares in Q4 2023, an estimated $1.39M.
  • Progeny 3 Inc first reported a position in Danimer Scientific, Inc. in Q2 2021 and held it in 10 quarters.
  • Progeny 3 Inc's Danimer Scientific, Inc. position peaked at $3.06M in Q1 2022.
  • 140 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2023.

Based on Progeny 3 Inc's 13F filing for Q4 2023, filed 14 Feb 2024.